Position statement for isotretinoin.
Gupta
Aditya K
AK
agupta@execulink.com
Lynde
Charles W
CW
Poulin
Yves
Y
Smith
Kevin
K
Lewis
Richard
R
Zip
Catherine
C
D002170:Canada; D032962:Consent Forms; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004346:Drug Information Services; D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D020407:Internet; D015474:Isotretinoin / Q000627:therapeutic use*; D011247:Pregnancy; D011258:Pregnancy Tests; D012308:Risk Management; D014481:United States
D003879:Dermatologic Agents; D015474:Isotretinoin